The People's Perspective on Medicine

New Alzheimer’s Drug Dropped

0 - 0 ratings

Terry Graedon

January 18, 2012

2 Comments

Terry Graedon

January 18, 2012

2 Comments

Disappointing results in a clinical trial have led to the abandonment of an experimental Alzheimer’s drug. The compound, dimebon, is an antihistamine and has been used for years as a cold remedy in Russia. Trials there suggested it might be beneficial against dementia. But in a well-controlled clinical trial it failed to demonstrate effectiveness. The companies behind the research, Pfizer and Medivation, have pulled the plug on this medication.

Rate this article

0- 0 ratings

About the Author

Terry Graedon

Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies.Read Terry's full bio.

Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.

The People's Perspective on Medicine

New Alzheimer’s Drug Dropped

Tired of the ads on our website?

Content

About Us

Get In Touch